Synaptogenix Inc (SNPX)

[SF Wolf]

Thanks for your insightful and informative reply coach.

Given that Bryostatin has not shown any significant side effects in many earlier cancer studies nor in their own Phase 2 study, I recall NTRP indicated they would ask FDA approval for Compassionate and/or Open Label use in their previous Phase 2 patients whose families requested it.

If the FDA granted Compassionate/Open Label use would that change your opinion?